printemailclick to share buttonfacebooktwitterlinkedin
Unfunded Intravenous (IV) Cancer Drugs

A difficult issue facing Ontarians is what to do when patients seek out very expensive cancer drugs which have not been approved for funding. Cancer Care Ontario is working with different levels of government to strengthen publicly funded programs for cancer drugs, as well as to assess efficacy, appropriateness and cost-effectiveness of different drugs.

On July 28, 2006, the Provincial Working Group on the Delivery of Oncology Medications for Private Payment in Ontario Hospitals submitted recommendations to the Ministry of Health and Long-Term Care (MOHLTC) for the provision of unfunded IV cancer drugs.

In the absence of any ministry policy on this issue, the documents are available as guidance to hospitals. They do not represent ministry or CCO policy.

Last modified: Mon, Jan 06, 2014
cancer care ontario | action cancer ontario   620 University Avenue Toronto Ontario, Canada M5G 2L7   Phone: 416.971.9800 Fax: 416.971.6888

Please help improve the quality of our website by answering 10 brief questions in our online survey. Would you like to participate?